selected scholarly activity
-
conferences
- An Audit of Fecal Occult Blood Testing in Hospital Inpatients. American Journal of Gastroenterology. S495-S495. 2013
- Temperature control for cryoglobulin sample collection. Clinical Biochemistry. 1121-1121. 2012
- Comparison between Abbott Precision Xceed Pro (PXP) and Nova Statstrip (StatStrip) glucose meters in neonates. Clinical Biochemistry. 1185-1186. 2011
- Vitamin D and cognition: A meta-analysis. Clinical Biochemistry. 1166-1166. 2011
- Evaluation of the Abbott Precision Xceed Pro (PXP)® glucose monitor for neonatal hypoglycemia. Clinical Biochemistry. 544-544. 2011
- Biospecimen collection, processing and storage protocol for the Canadian Longitudinal Study on Aging (CLSA). Clinical Biochemistry. 788-788. 2010
- Utility of monitoring mycophenolic acid in solid organ transplant patients. Clinical Biochemistry. 1263-1263. 2008
- A plea for intra-laboratory reference limits. Part 2. A bimodal retrospective concept for determining reference limits from intra-laboratory databases demonstrated by catalytic activity concentrations of enzymes. Clinical Chemistry and Laboratory Medicine. 1043-1057. 2007
- Brain type carnosinase: A potential serum biomarker of dementia. Clinical Biochemistry. 1096-1096. 2006
- Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the heart outcomes prevention evaluation (HOPE) Study. Circulation. 871-871. 2006
- Effects on rounding on quality control. Clinical Chemistry. A223-A223. 2005
- Performance of the Abbott PCx glucometer in the neonatal intensive care unit.. Clinical Chemistry. A148-A148. 2003
- Evaluation of HemogloBind™ for Removal of o-Raffinose Cross-Linked Hemoglobin (Hemolink™) from Serum. Clinical Chemistry. 1796-1797. 1997
- CHANGES IN SERUM CARNOSINASE ACTIVITY IN PATIENTS WITH THYROID-DISEASES. Clinical Chemistry. 1138-1138. 1990
-
journal articles
- Reference Interval Harmonization: Harnessing the Power of Big Data Analytics to Derive Common Reference Intervals across Populations and Testing Platforms. Clinical Chemistry. 69:991-1008. 2023
- Performance of saliva compared with nasopharyngeal swab for diagnosis of COVID-19 by NAAT in cross-sectional studies: Systematic review and meta-analysis. Clinical Biochemistry. 117:84-93. 2023
- Increased prevalence of loneliness and associated risk factors during the COVID-19 pandemic: findings from the Canadian Longitudinal Study on Aging (CLSA). BMC International Health and Human Rights. 23:872. 2023
- Detection of Large Genomic RNA via DNAzyme‐Mediated RNA Cleavage and Rolling Circle Amplification: SARS‐CoV‐2 as a Model. Chemistry - A European Journal. 29:e202300075. 2023
- Persistent COVID-19 symptoms in community-living older adults from the Canadian Longitudinal Study on Aging (CLSA). Communications Medicine. 3:36. 2023
- Obesity and adverse childhood experiences in relation to stress during the COVID-19 pandemic: an analysis of the Canadian Longitudinal Study on Aging. International Journal of Obesity. 47:197-206. 2023
- Three on Three: Universal and High-Affinity Molecular Recognition of the Symmetric Homotrimeric Spike Protein of SARS-CoV-2 with a Symmetric Homotrimeric Aptamer. Journal of the American Chemical Society. 144:23465-23473. 2022
- Frailty and the impacts of the COVID-19 pandemic on community-living middle-aged and older adults: an analysis of data from the Canadian Longitudinal Study on Aging (CLSA). Age and Ageing. 51:afac289. 2022
- Multimorbidity resilience and COVID-19 pandemic self-reported impact and worry among older adults: a study based on the Canadian Longitudinal Study on Aging (CLSA). BMC Geriatrics. 22:92. 2022
- Symptoms of depression and anxiety, and unmet healthcare needs in adults during the COVID-19 pandemic: a cross-sectional study from the Canadian Longitudinal Study on Aging. BMC International Health and Human Rights. 22:2242. 2022
- Cohort profile: genomic data for 26 622 individuals from the Canadian Longitudinal Study on Aging (CLSA). BMJ Open. 12:e059021-e059021. 2022
- Investigation of discordant SARS-CoV-2 RT-PCR results using minimally processed saliva. Scientific Reports. 12:2806. 2022
- The complexity of examining laboratory-based biological markers associated with mortality in hospitalized patients during early phase of the COVID-19 pandemic: A systematic review and evidence map. PLoS ONE. 17:e0273578-e0273578. 2022
- A longitudinal analysis of the impact of the COVID-19 pandemic on the mental health of middle-aged and older adults from the Canadian Longitudinal Study on Aging. Nature Aging. 1:1137-1147. 2021
- High‐Affinity Dimeric Aptamers Enable the Rapid Electrochemical Detection of Wild‐Type and B.1.1.7 SARS‐CoV‐2 in Unprocessed Saliva. Angewandte Chemie International Edition. 60:24266-24274. 2021
- Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA library. Nucleic Acids Research (NAR). 49:7267-7279. 2021
- Cohort Profile: The Canadian Longitudinal Study on Aging (CLSA). International Journal of Epidemiology. 48:1752-1753j. 2019
- Corrigendum to: Cohort Profile: The Canadian Longitudinal Study on Aging (CLSA). International Journal of Epidemiology. 48:2066-2066. 2019
- Corrigendum to “Biomarkers of cadmium, lead and mercury exposure in relation with early biomarkers of renal dysfunction and diabetes: Results from a pilot study among aging Canadian” [Toxicol. Lett. 312 (2019) 148–156]. Toxicology Letters. 313:207-207. 2019
- Biomarkers of cadmium, lead and mercury exposure in relation with early biomarkers of renal dysfunction and diabetes: Results from a pilot study among aging Canadians. Toxicology Letters. 312:148-156. 2019
- PROCEEDINGS OF THE CANADIAN FRAILTY NETWORK WORKSHOP: IDENTIFYING BIOMARKERS OF FRAILTY TO SUPPORT FRAILTY RISK ASSESSMENT, DIAGNOSIS AND PROGNOSIS. TORONTO, JANUARY 15, 2018. Journal of Frailty and Aging. 8:1-11. 2019
- A comprehensive assessment of immunophenotyping performed in cryopreserved peripheral whole blood. Cytometry Part B - Clinical Cytometry. 94:818-826. 2018
- Candidate recommendations for protein electrophoresis reporting from the Canadian Society of Clinical Chemists Monoclonal Gammopathy Working Group. Clinical Biochemistry. 51:10-20. 2018
- The relation between DNA methylation patterns and serum cytokine levels in community-dwelling adults: a preliminary study. BMC Genetics. 18:57. 2017
- National Survey of Adult and Pediatric Reference Intervals in Clinical Laboratories across Canada: A Report of the CSCC Working Group on Reference Interval Harmonization. Clinical Biochemistry. 50:925-935. 2017
- Statistical methods used in the calculation of geriatric reference intervals: a systematic review. Clinical Chemistry and Laboratory Medicine. 54:377-388. 2016
- A systematic review of BNP and NT-proBNP in the management of heart failure: overview and methods. Heart Failure Reviews. 19:413-419. 2014
- B-type natriuretic peptide-guided therapy: a systematic review. Heart Failure Reviews. 19:553-564. 2014
- BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review. Heart Failure Reviews. 19:453-470. 2014
- BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure. Heart Failure Reviews. 19:471-505. 2014
- Erratum to: Conflict of interest declaration. Heart Failure Reviews. 19:565-565. 2014
- Incremental predictive value of natriuretic peptides for prognosis in the chronic stable heart failure population: a systematic review. Heart Failure Reviews. 19:521-540. 2014
- Incremental value of natriuretic peptide measurement in acute decompensated heart failure (ADHF): a systematic review. Heart Failure Reviews. 19:507-519. 2014
- Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review. Heart Failure Reviews. 19:439-451. 2014
- Prediction of clinical outcomes using B-type natriuretic peptides in the general population: a systematic review. Heart Failure Reviews. 19:541-551. 2014
- Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence. Heart Failure Reviews. 19:421-438. 2014
- Fecal Occult Blood Testing as a Diagnostic Test in Symptomatic Patients is not Useful: A Retrospective Chart Review. Canadian Journal of Gastroenterology and Hepatology. 28:421-426. 2014
- Validating Chronic Disease Ascertainment Algorithms for Use in the Canadian Longitudinal Study on Aging*. Canadian Journal on Aging. 32:232-239. 2013
- Hematocrit correction does not improve glucose monitor accuracy in the assessment of neonatal hypoglycemia. Clinical Chemistry and Laboratory Medicine. 51:1627-1635. 2013
- Vitamin D, cognition, and dementia. Neurology. 79:1397-1405. 2012
- Chapter 8: Meta-analysis of Test Performance When There is a “Gold Standard”. Journal of General Internal Medicine. 27:56-66. 2012
- Chapter 9: Options for Summarizing Medical Test Performance in the Absence of a “Gold Standard”. Journal of General Internal Medicine. 27:67-75. 2012
- Utility of Urine Myoglobin for the Prediction of Acute Renal Failure in Patients with Suspected Rhabdomyolysis: A Systematic Review. Clinical Chemistry. 55:2190-2197. 2009
- Feasibility of Biological Specimen Collection for the Canadian Longitudinal Study on Aging (CLSA) Biorepository. Canadian Journal on Aging. 28:261-274. 2009
- The Canadian Longitudinal Study on Aging (CLSA). Canadian Journal on Aging. 28:221-229. 2009
- A systematic review of BNP as a predictor of prognosis in persons with coronary artery disease. Clinical Biochemistry. 41:260-265. 2008
- Diagnostic accuracy of BNP and NT-proBNP in patients presenting to acute care settings with dyspnea: A systematic review. Clinical Biochemistry. 41:250-259. 2008
- Evidence for the use of B-type natriuretic peptides for screening asymptomatic populations and for diagnosis in primary care. Clinical Biochemistry. 41:240-249. 2008
- Monitoring the response to pharmacologic therapy in patients with stable chronic heart failure: Is BNP or NT-proBNP a useful assessment tool?. Clinical Biochemistry. 41:266-276. 2008
- Physiological, pathological, pharmacological, biochemical and hematological factors affecting BNP and NT-proBNP. Clinical Biochemistry. 41:231-239. 2008
- Utility of monitoring mycophenolic acid in solid organ transplant patients.. Evidence report/technology assessment. 1-131. 2008
- Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: A systematic overview and meta-analysis of prospective studies. Diabetes Research and Clinical Practice. 78:305-312. 2007
- Brain type carnosinase in dementia: a pilot study. BMC Neurology. 7:38. 2007
- Erratum. Clinical Chemistry and Laboratory Medicine. 45:1570. 2007
- Reproducibility of impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) classification: a systematic review. Clinical Chemistry and Laboratory Medicine. 45:1180-1185. 2007
- Screening for hypoglycemia at the bedside in the neonatal intensive care unit (NICU) with the Abbott PCx glucose meter. BMC Pediatrics. 6:28. 2006
- Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure.. Evidence report/technology assessment. 1-147. 2006
- Comparative Impact of Multiple Biomarkers and N-Terminal Pro-Brain Natriuretic Peptide in the Context of Conventional Risk Factors for the Prediction of Recurrent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation. 114:201-208. 2006
- Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose.. Evidence report/technology assessment (Summary). 1-11. 2005
- Carbamylated hemoglobin and carbamylated plasma protein in hemodialyzed patients. Kidney International. 53:488-495. 1998
- Regulation of carnosine metabolism: The subcellular localization of carnosinase in liver. Clinical Biochemistry. 21:315-318. 1988